198 related articles for article (PubMed ID: 31995557)
1. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
[TBL] [Abstract][Full Text] [Related]
2. Vaginal progesterone to reduce preterm birth among HIV-infected pregnant women in Zambia: a feasibility study protocol.
Price JT; Mollan KR; Fuseini NM; Freeman BL; Mulenga HB; Corbett AH; Vwalika B; Stringer JSA
Pilot Feasibility Stud; 2018; 4():21. PubMed ID: 28729911
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study.
Price JT; Mabula-Bwalya CM; Freeman BL; Carda-Auten J; Phiri WM; Chibwe K; Kantumoya P; Vwalika B; Stringer JSA; Golin CE
PLoS One; 2020; 15(9):e0238748. PubMed ID: 32970697
[TBL] [Abstract][Full Text] [Related]
4. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial.
Hassan SS; Romero R; Vidyadhari D; Fusey S; Baxter JK; Khandelwal M; Vijayaraghavan J; Trivedi Y; Soma-Pillay P; Sambarey P; Dayal A; Potapov V; O'Brien J; Astakhov V; Yuzko O; Kinzler W; Dattel B; Sehdev H; Mazheika L; Manchulenko D; Gervasi MT; Sullivan L; Conde-Agudelo A; Phillips JA; Creasy GW;
Ultrasound Obstet Gynecol; 2011 Jul; 38(1):18-31. PubMed ID: 21472815
[TBL] [Abstract][Full Text] [Related]
5. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial.
Price JT; Vwalika B; Freeman BL; Cole SR; Saha PT; Mbewe FM; Phiri WM; Peterson M; Muyangwa D; Sindano N; Mwape H; Smithmyer ME; Kasaro MP; Rouse DJ; Goldenberg RL; Chomba E; Stringer JSA
Lancet HIV; 2021 Oct; 8(10):e605-e613. PubMed ID: 34509197
[TBL] [Abstract][Full Text] [Related]
6. Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data.
Romero R; Conde-Agudelo A; El-Refaie W; Rode L; Brizot ML; Cetingoz E; Serra V; Da Fonseca E; Abdelhafez MS; Tabor A; Perales A; Hassan SS; Nicolaides KH
Ultrasound Obstet Gynecol; 2017 Mar; 49(3):303-314. PubMed ID: 28067007
[TBL] [Abstract][Full Text] [Related]
7. Preventing Preterm Birth with Progesterone in Women with a Short Cervical Length from a Low-Risk Population: A Multicenter Double-Blind Placebo-Controlled Randomized Trial.
van Os MA; van der Ven AJ; Kleinrouweler CE; Schuit E; Kazemier BM; Verhoeven CJ; de Miranda E; van Wassenaer-Leemhuis AG; Sikkema JM; Woiski MD; Bossuyt PM; Pajkrt E; de Groot CJ; Mol BW; Haak MC
Am J Perinatol; 2015 Aug; 32(10):993-1000. PubMed ID: 25738790
[TBL] [Abstract][Full Text] [Related]
8. Vaginal progesterone for prevention of preterm labor in asymptomatic twin pregnancies with sonographic short cervix: a randomized clinical trial of efficacy and safety.
El-Refaie W; Abdelhafez MS; Badawy A
Arch Gynecol Obstet; 2016 Jan; 293(1):61-67. PubMed ID: 26044148
[TBL] [Abstract][Full Text] [Related]
9. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.
Dugoff L; Berghella V; Sehdev H; Mackeen AD; Goetzl L; Ludmir J
Ultrasound Obstet Gynecol; 2018 May; 51(5):573-579. PubMed ID: 28940481
[TBL] [Abstract][Full Text] [Related]
10. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Early Preterm Birth Despite Vaginal Progesterone Therapy in Singletons with Short Cervix.
Boelig RC; Naert MN; Fox NS; Hennessy S; Chervoneva I; Berghella V; Roman A
Am J Perinatol; 2020 Nov; 37(13):1289-1295. PubMed ID: 32344443
[TBL] [Abstract][Full Text] [Related]
12. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial.
van Zijl MD; Koullali B; Naaktgeboren CA; Schuit E; Bekedam DJ; Moll E; Oudijk MA; van Baal WM; de Boer MA; Visser H; van Drongelen J; van de Made FW; Vollebregt KC; Muller MA; Bekker MN; Brons JTJ; Sueters M; Langenveld J; Franssen MT; Schuitemaker NW; van Beek E; Scheepers HCJ; de Boer K; Tepe EM; Huisjes AJM; Hooker AB; Verheijen ECJ; Papatsonis DN; Mol BWJ; Kazemier BM; Pajkrt E
BMC Pregnancy Childbirth; 2017 Sep; 17(1):284. PubMed ID: 28870155
[TBL] [Abstract][Full Text] [Related]
13. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
[TBL] [Abstract][Full Text] [Related]
14. Vaginal progesterone in women with twin gestations complicated by short cervix: a retrospective cohort study.
Brubaker SG; Pessel C; Zork N; Gyamfi-Bannerman C; Ananth CV
BJOG; 2015 Apr; 122(5):712-8. PubMed ID: 25428801
[TBL] [Abstract][Full Text] [Related]
15. Cervical cerclage, pessary, or vaginal progesterone in high-risk pregnant women with short cervix: a randomized feasibility study.
Care A; Jackson R; O'Brien E; Leigh S; Cornforth C; Haycox A; Whitworth M; Lavender T; Alfirevic Z
J Matern Fetal Neonatal Med; 2021 Jan; 34(1):49-57. PubMed ID: 30895903
[No Abstract] [Full Text] [Related]
16. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial.
Saccone G; Maruotti GM; Giudicepietro A; Martinelli P;
JAMA; 2017 Dec; 318(23):2317-2324. PubMed ID: 29260226
[TBL] [Abstract][Full Text] [Related]
17. 17-alpha-hydroxyprogesterone caproate versus vaginal progesterone suppository for the prevention of preterm birth in women with a sonographically short cervix: A randomized controlled trial.
Pirjani R; Heidari R; Rahimi-Foroushani A; Bayesh S; Esmailzadeh A
J Obstet Gynaecol Res; 2017 Jan; 43(1):57-64. PubMed ID: 27775195
[TBL] [Abstract][Full Text] [Related]
18. Treatment options and recommendations to reduce preterm births in women with short cervix.
Slager J; Lynne S
J Midwifery Womens Health; 2012 Jul; 57 Suppl 1():S12-8. PubMed ID: 22776244
[TBL] [Abstract][Full Text] [Related]
19. Association of Vaginal Progesterone Treatment With Prevention of Recurrent Preterm Birth.
Nelson DB; Lafferty A; Venkatraman C; McDonald JG; Eckert KM; McIntire DD; Spong CY
JAMA Netw Open; 2022 Oct; 5(10):e2237600. PubMed ID: 36315147
[TBL] [Abstract][Full Text] [Related]
20. Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial.
Price JT; Vwalika B; Freeman BL; Cole SR; Mulenga HB; Winston J; Mbewe FM; Chomba E; Mofenson LM; Rouse DJ; Goldenberg RL; Stringer JSA
BMC Pregnancy Childbirth; 2019 Feb; 19(1):81. PubMed ID: 30813934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
